BFRIW Projected Dividend Yield
Wt Exp 10/27/2026/Biofrontera Inc ( NASDAQ : BFRIW )Biofrontera Inc. is a biopharmaceutical company. Co. is focused on commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Co.'s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its principal licensed product is Ameluz, which is a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy. 20 YEAR PERFORMANCE RESULTS |
BFRIW Dividend History Detail BFRIW Dividend News BFRIW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |